levodopa has been researched along with Clerambault Syndrome in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (76.92) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yung, CY | 1 |
Gottschal, T; Minderhoud, JM; Nicolai, G; van Woerkom, TC | 1 |
Kozlova, TA | 1 |
Marsden, CD | 1 |
Aronowitz, JS; Gordon, MF; Kane, JM; Lieberman, JA; Pollack, S; Safferman, AZ | 1 |
Friedman, JH; Koller, WC; Lannon, MC; LeWitt, PA; O'Brien, CF; Pahwa, R; Seeberger, LC; Smith, D; Trosch, RM | 1 |
Baldessarini, RJ; Fischer, JE | 1 |
Lamprecht, F | 1 |
Klerman, GL; Krauthammer, C | 1 |
De Vries, A; Douer, D; Naftalin, J; Pinkhas, J; Weinberger, A | 1 |
Downes, JJ; Evenden, JL; Morris, RG; Robbins, TW; Roberts, AC; Sahakian, BJ | 1 |
Schnaberth, G | 1 |
Higurashi, M; Nomura, Y; Segawa, M | 1 |
4 review(s) available for levodopa and Clerambault Syndrome
Article | Year |
---|---|
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
Parkinson's disease.
Topics: Cognition Disorders; Disabled Persons; Gait; Humans; Levodopa; Medical Audit; Movement Disorders; Neurocognitive Disorders; Neurosurgery; Parkinson Disease; Postural Balance; Practice Guidelines as Topic; Speech Disorders | 1994 |
The use of clozapine in neurologic disorders.
Topics: Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Humans; Levodopa; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Tremor | 1994 |
Epilepsy and schizophrenia: a neurochemical bridge.
Topics: Amphetamine; Anticonvulsants; Brain; Butyrophenones; Disulfiram; Dopamine; Dopamine beta-Hydroxylase; Epilepsy; Humans; Huntington Disease; Levodopa; Neurocognitive Disorders; Phenothiazines; Phenytoin; Receptors, Dopamine; Schizophrenia | 1977 |
2 trial(s) available for levodopa and Clerambault Syndrome
Article | Year |
---|---|
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
Neurotransmitters in the treatment of patients with severe head injuries.
Topics: Adolescent; Adult; Brain Injuries; Child; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurocognitive Disorders; Physostigmine; Prognosis; Verbal Behavior | 1982 |
8 other study(ies) available for levodopa and Clerambault Syndrome
Article | Year |
---|---|
[Etiology, pathogenesis and treatment of tics in children].
Topics: Adolescent; Benactyzine; Child; Child, Preschool; Chlorpromazine; Female; Galantamine; Humans; Levodopa; Male; Neurocognitive Disorders; Neurologic Examination; Neurotic Disorders; Tic Disorders | 1980 |
Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.
Topics: Aged; Ambulatory Care; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neurocognitive Disorders; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Patient Admission; Retrospective Studies; Treatment Outcome | 1998 |
Substitute and alternative neurotransmitters in neuropsychiatric illness.
Topics: Amines; Amino Acids; Animals; Brain; Catecholamines; Disease Models, Animal; Hemodynamics; Hepatic Encephalopathy; Humans; Levodopa; Liver; Nerve Endings; Neurocognitive Disorders; Neurotransmitter Agents; Serotonin; Sympatholytics; Synaptic Transmission | 1977 |
Secondary mania: manic syndromes associated with antecedent physical illness or drugs.
Topics: Adrenal Cortex Hormones; Adult; Bipolar Disorder; Bromides; Epilepsy, Temporal Lobe; Humans; Isoniazid; Levodopa; Middle Aged; Neoplasms; Neurocognitive Disorders; Postoperative Complications; Procarbazine; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotropic Drugs; Renal Dialysis | 1978 |
Possible response of acute psychosis in hepatic encephalopathy to levodopa.
Topics: Adult; Budd-Chiari Syndrome; Hepatic Encephalopathy; Humans; Levodopa; Male; Neurocognitive Disorders | 1976 |
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction.
Topics: Aged; Attention; Drug Therapy, Combination; Female; Form Perception; Humans; Levodopa; Male; Middle Aged; Neurocognitive Disorders; Neuropsychological Tests; Parkinson Disease; Pattern Recognition, Visual; Psychomotor Performance; Reaction Time; Trihexyphenidyl | 1989 |
["Parkinson plus." Multisystem involvement in Parkinson disease].
Topics: Brain Ischemia; Dopamine; Humans; Levodopa; Muscle Rigidity; Neurocognitive Disorders; Parkinson Disease | 1986 |
Rett syndrome--an early catecholamine and indolamine deficient disorder?
Topics: 5-Hydroxytryptophan; Adolescent; Basal Ganglia; Catecholamines; Child; Child, Preschool; Droxidopa; Electroencephalography; Female; Humans; Intellectual Disability; Levodopa; Locus Coeruleus; Neurocognitive Disorders; Raphe Nuclei; Serotonin; Sleep, REM; Stereotyped Behavior; Syndrome | 1985 |